To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: Use of rhBMP in Cervical Spine Fusion Linked to Life-Threatening Adverse Events URL: http://www.pslgroup.com/dg/224D52.htm Doctor's Guide July 2, 2008
ROCKVILLE, Md -- July 2, 2008 -- The US Food and Drug Administration (FDA) today informed healthcare professionals of reports of life-threatening complications associated with recombinant human Bone Morphogenetic Protein (rhBMP) when used in the cervical spine.